PainChek General Discussion, page-196

FDA all depends on the classification of the product, either way it will be in the bag by end of this year for eventual commercialisation in the US.

It is clear the near term goal is to have PainChek succeed in Australia, and then later this year expand into Europe. The market in Australia is very significant and I won't be disappointed if the EU rollout is delayed by a quarter or two.

It sounds like we will see a few deals strung together over the next few months as on boarding continues with the new Android Application complete.

From 5:40 in the interview PD mentions:
"We are working with a large number of residential aged care groups now, large ones, medium ones, small ones and we're basically looking to implement it in their care management systems throughout Australia"

Another clinical specialist coming on board in April to assist with technical support is a sign of the inbound demand to come, no point hiring a full time position if there isn't significant work ahead.

Having the in home consumer version out by mid year will only increase uptake of the application and something shareholders should look forward too. Whilst PCK have been quiet, the register has only been tightening.